About 9 Trademarks found that are owned by Pharmaessentia Corporation

PHARMACEUTICAL ESSENTIAL

The mark consists of the word "BESREMi" in bold red characters, in which "BESREM" in upper case and "I" in lower case with a design to the left. The design consists of a yellow sphere partially wrapped by light blue and dark blue sections. There is a white luster shown at the upper right of the sphere.

Immunostimulants; pre-filled syringes containing PEGylated interferons for medical purposes; anticancer pharmaceuticals; medicines for human purposes of treating cancers, polycythemia vera (PV) and other myeloproliferative neoplasms (MPNs); western medicine, namely, ropeginterferon alfa-2b; active pharmaceutical ingredients for active pharmaceutical ingredients of ropeginterferon alfa-2b for treating cancers, PV and other MPNs; medicinal agent for human use, namely, pharmaceuticals for treating cancers or viral infections; biological preparations for medical purposes, namely, ropeginterferon alfa-2b; chemical preparations for medical purposes, namely, for cancers, PV and other MPNs; chemical-pharmaceutical preparations, namely, for treating cancers, PV and other MPNs; albuminous preparations for medical purposes; chemical preparations for pharmaceutical purposes, namely, for treating cancers, PV and other MPNs; pharmaceutical preparations for treating cancers, PV and other MPNs

Pharmaceutical preparations, namely, antineoplastic and immunomodulating agents

Pharmaceutical preparations, namely, ropeginterferon alfa-2b, contained in pen injectors for treatment of viral infections, cancers, polycythemia vera, essential thrombocythemia, myelofibrosis, and/or other myeloproliferative neoplasms; Pharmaceutical preparations contained in pen injectors; Pharmaceutical preparations contained in pen injectors for treatment of myeloproliferative neoplasms; Pharmaceutical preparations contained in injectors for treatment of myeloproliferative neoplasms; Pharmaceutical preparations contained in injectors; Pharmaceutical preparations, namely, ropeginterferon alfa-2b, contained in injectors for treatment of viral infections, cancers, polycythemia vera, essential thrombocythemia, myelofibrosis, and/or other myeloproliferative neoplasms

Pharmaceutical preparations contained in pen injectors; Pharmaceutical preparations, namely, ropeginterferon alfa-2b, contained in injectors for treatment of viral infections, cancers, polycythemia vera, essential thrombocythemia, myelofibrosis, and/or other myeloproliferative neoplasms; Pharmaceutical preparations contained in injectors for treatment of myeloproliferative neoplasms; Pharmaceutical preparations contained in pen injectors for treatment of myeloproliferative neoplasms; Pharmaceutical preparations, namely, ropeginterferon alfa-2b, contained in pen injectors for treatment of viral infections, cancers, polycythemia vera, essential thrombocythemia, myelofibrosis, and/or other myeloproliferative neoplasms; Pharmaceutical preparations contained in injectors

Color is not claimed as a feature of the mark.

The mark consists of the stylized wording "PHARMAESSENTIA" in white, with a green background.

herbal supplements; nutritional supplements; dietary supplements